HANTAVIRUS - ANVISA Registration 80142170075
Access comprehensive regulatory information for HANTAVIRUS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80142170075 and manufactured by Fundação Oswaldo Cruz - Instituto de Tecnologia em Imunobiológicos -. The registration is held by FUNDACAO OSWALDO CRUZ with validity until Apr 07, 2035.
This page provides complete technical specifications for this device, regulatory compliance details, 3 companies making the same product including EUROIMMUN AG, NOVATEC IMMUNDIAGNOSTICA GMBH TECHNOLOGIE & WALDPARK, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
80142170075
25351370134202411
33781055000135
Company Information
Dates and Status
Apr 07, 2025
07/04/2035
09/18/2025 19:00:01
HANTAVÍRUS
Anti-Hanta Virus Pool 2 “America” ELISA (IgG)
EUROIMMUN AG
10338930257
Aug 23, 2021
HANTAVÍRUS
Anti-Hanta Virus Pool 2 “America” ELISA (IgG)
Not specified
10338930257
Aug 23, 2021
HANTAVÍRUS
Anti-Hanta Virus Pool 2 “America” ELISA (IgM)
Not specified
10338930258
Aug 23, 2021
HANTAVÍRUS
Anti-Hanta Virus Pool 2 “America” ELISA (IgM)
EUROIMMUN AG
10338930258
Aug 23, 2021
HANTAVÍRUS
NovaLisa® Hantavirus IgM ELISA
Not specified
80464810561
Jan 22, 2018

